降糖药物对T2DM患者心衰风险影响研究的进展  

Research progress of influence of hypoglycemic drugs on heart failure risk in T2DM patients

作　　者：赵宵丹 丛丽[1] ZHAO Xiao-dan;CONG Li(Department of Endocrinology,Second Affiliated Hospital of Harbin Medical University,Harbin,Heilongjiang,150081,China)

机构地区：[1]哈尔滨医科大学附属第二医院内分泌科,黑龙江哈尔滨150081

出　　处：《心血管康复医学杂志》2021年第4期502-505,共4页Chinese Journal of Cardiovascular Rehabilitation Medicine

摘　　要：2型糖尿病(T2DM)是心衰(HF)的危险因素之一。大量试验对多种降糖药物的心血管安全性进行了评估。本文就各类降糖药对于T2DM患者心血管事件及HF的风险影响作一综述,旨在为临床安全、有效用药提供新的思路.Type 2 diabetes mellitus(T2DM)is one of risk factor for heart failure(HF).A large number of trials have evaluated cardiovascular safety of a variety of hypoglycemic drugs.The present article makes a review for influence of various hypoglycemic drugs on the risk of cardiovascular events and HF in T2DM patients,aiming at providing new thinking for clinical safe and effective medication。

关 键 词：心力衰竭 糖尿病 2型 降血糖药 

分 类 号：R541.6[医药卫生—心血管疾病]